Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | GJB2 | P29033 | 5/20 | 0.52 |
| ▸ | GBA1 | P04062 | 2/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.47 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.47 |
| ▸ | CETP | P11597 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28995607 | 1.00 | MAPK1 (0.61) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL28264760 | 1.00 | MAPK1 (0.61) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL17640864 | 1.00 | MAPK1 (0.61) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL28364147 | 1.00 | MAPK1 (0.61) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| Hydrochloric Acid SCHEMBL9403705 | 0.99 | MAPK1 (0.60) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| Hydrochloric Acid SCHEMBL9403706 | 0.99 | MAPK1 (0.60) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL27710626 | 0.98 | MAPK1 (0.59) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL28061284 | 0.98 | MAPK1 (0.59) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL8614698 | 0.98 | MAPK1 (0.59) | MAPK1GJB2GBA1LGALS8LGALS3 | |
| SCHEMBL28070713 | 0.98 | MAPK1 (0.59) | MAPK1GJB2GBA1LGALS8LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160017323-A1 | CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE | ISIS PHARMACEUTICALS, INC. (US) | 2016-01-21 | — | — | US | disclosed |
| US-9181550-B2 | Compositions and methods for modulating apolipoprotein (a) expression | ISIS PHARMACEUTICALS, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| US-9145558-B2 | Compositions and methods for modulating HBV expression | ISIS PHARMACEUTICALS, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-9127276-B2 | Conjugated antisense compounds and their use | ISIS PHARMACEUTICALS, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-20140343123-A1 | CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE | ISIS PHARMACEUTICALS, INC. (US) | 2014-11-20 | — | — | US | disclosed |